Hospital for Special Surgery

Team members from HSS kicked off the Giants 100th season by supporting The Giants Foundation 5K at MetLife Stadium on Saturday, September 7th. After the race, fans stopped by the HSS Paramus table to grab some giveaways and snag autographs from Giants Legends Mario Manningham and Corey Webster! HSS is proud to be the Official Hospital of the New York Football Giants! 

In this episode of the Move Better Podcast presented by HSS, David W. Altchek, MD (sports medicine surgeon) is joined by hip and knee surgeons Jonathan Vigdorchik, MD and Jose A Rodriguez, MD, who are experts in hip replacement surgery. Together, they discuss the advantages and disadvantages of the anterior and posterior approaches for hip replacement surgery and explain the benefits and recovery time for each. Listen here: https://lnkd.in/e-VZnBQA

On this Patriot Day, we remember.

In this new podcast series, some of the world’s top specialists debate popular orthopedic treatment alternatives — in terms even I can understand. Quite interesting and helpful….

In this episode of the Move Better Podcast presented by HSS, David W. Altchek, MD (sports medicine surgeon) is joined by Mathias Bostrom, MD (Associate Surgeon-in-Chief and Director of Quality and Safety) and David Mayman, MD (chief of the adult reconstruction and joint replacement service) as they discuss who is a candidate for a total knee replacement versus a partial knee replacement; the role one’s age, activity level and genetics play in the decision; and how technology has improved recovery times. Listen here: https://lnkd.in/eHQx8W8q

A digital pathology approach that can distinguish subtypes of rheumatoid arthritis (RA) using a machine-learning tool created by HSS and Weill Cornell Medicine investigators may help scientists find ways to improve care for this complex condition. The study published August 29 in Nature shows that artificial intelligence and machine learning technologies can effectively and efficiently subtype pathology samples from patients with RA. For this study, Dr. Richard Bell, an Instructor in the HSS Research Institute and Arthritis and Tissue Degeneration Program, and Lionel B. Ivashkiv, MD, Chief Scientific Officer at HSS teamed up with Dr. Fei Wang, a professor of population health sciences and the founding director of the Institute of AI for Digital Health (AIDH) in the Department of Population Health Sciences at Weill Cornell Medicine. “Our study addresses the analytical bottleneck of pathology research,” Dr. Bell said. “It is very time-consuming and tedious.” “Our tool automates the analysis of pathology slides, which may one day lead to more precise and efficient disease diagnosis and personalized treatment for RA,” said Dr. Wang. “It shows that machine learning can potentially transform pathological assessment of many diseases.” The technology may provide new insights into the disease by detecting unexpected tissue changes that humans might miss. By saving pathologists time on subtyping, the tool may also decrease the cost and increase the efficiency of clinical trials testing treatments for patients with different subtypes of RA. “This work represents an important advance in analyzing RA tissues that can be applied for the benefit of patients” Dr. Ivashkiv said. https://lnkd.in/daT6hAtf

We would like to wish you all a happy and safe Labor Day. Today and every day, we thank our clinicians and staff for their continuous dedication to providing the highest quality patient care and service.

Recently, HSS rheumatologists Jessica K. Gordon, MD, MS and Kim (Showalter) Lakin, MD, MS, attended the 2024 National Scleroderma Foundation Patient Conference in Bellevue, WA. During the conference, which provides an inclusive educational event for anyone impacted by scleroderma, Dr. Gordon gave two talks (Scleroderma 101; Gastrointestinal Issues in Systemic Sclerosis) and Dr. Lakin presented her research focused on scleroderma skin biomarker development and gave a patient lecture entitled, "The Pregnancy Journey in Scleroderma."

A new study published in Nature Portfolio, by researchers at HSS and others has identified a gene pathway involved in the formation of fibrous scar tissue that represents a major cause of failed joint replacements. Findings demonstrated this fibrosis can be prevented and even reversed by blocking the pathway, potentially opening the door to improved surgical outcomes in these patients. Loosening of joint implants, such as hips and knees, without infection or trauma is responsible for as many as 40 percent of failed joint replacements. In these cases, called aseptic loosening, scar tissue accumulates around the implant instead of the bone, preventing the new joint from regaining stability. “Revision surgery is akin to pressing a ‘reset button’ on the cells in the patient’s body, in the hopes that this time the cells will correctly form bone around the implant rather than fibrous tissue,” said Vincentius (Jeremy) Suhardi, MD, PhD, orthopedic surgical resident at HSS, and first author of the study. “This finding for the first time opens up the possibility of treating aseptic loosening with a drug that inhibits ADGRF5,” Dr. Suhardi said. We are planning to collaborate with strategic partners to further develop this therapy and to test its efficacy not just in aseptic loosening but also in other orthopedic-related fibrotic pathologies. https://lnkd.in/eQDiCiVs

Congratulations to the winners from this year’s Mets on the Move program, presented by HSS! The students who took the most steps at each participating school were honored with their physical education teachers during an on-field ceremony at Citi Field. Mets on the Move is a fitness program dedicated to keeping kids active and healthy. This year, Mets front office staff and members of our Athlete Health team worked 3,000 students across six local elementary schools throughout the month of month of May to coincide with National Physical Fitness and Sports Month. New York Mets